(19)
(11) EP 4 580 659 A1

(12)

(43) Date of publication:
09.07.2025 Bulletin 2025/28

(21) Application number: 23762239.4

(22) Date of filing: 29.08.2023
(51) International Patent Classification (IPC): 
A61K 39/00(2006.01)
A61P 37/08(2006.01)
A61P 17/00(2006.01)
C07K 16/28(2006.01)
(52) Cooperative Patent Classification (CPC):
C07K 2317/76; C07K 16/2866; C07K 2317/21; A61P 37/08; A61P 17/00; A61K 2039/505
(86) International application number:
PCT/EP2023/073630
(87) International publication number:
WO 2024/047021 (07.03.2024 Gazette 2024/10)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
KH MA MD TN

(30) Priority: 29.08.2022 US 202263401756 P
02.02.2023 EP 23315021

(71) Applicant: Sanofi Biotechnology
94250 Gentilly (FR)

(72) Inventors:
  • LAWS, Elizabeth
    Cambridge, Massachusetts 02141 (US)
  • MANNENT, Leda
    94250 Gentilly (FR)
  • MARTINCOVA, Renata
    94250 Gentilly (FR)
  • STJEPANOVIC, Aleksandra
    94250 Gentilly (FR)

(74) Representative: Zwicker, Jörk 
ZSP Patentanwälte PartG mbB Hansastraße 32
80686 München
80686 München (DE)

   


(54) METHODS FOR TREATING CHRONIC INDUCIBLE COLD URTICARIA BY ADMINISTERING AN IL-4R ANTAGONIST